SYMA RIZVI: Open Payments
NPI 1992989164 · PIKESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,048 in 87 payments from 21 companies in 2025. Trend: 2023 $1,761 · 2024 $2,043 · 2025 $2,048
Food & beverage: $2,048
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $315 |
| PFIZER INC. | 12 | $227 |
| Corcept Therapeutics | 5 | $219 |
| Novo Nordisk Inc | 13 | $213 |
| Amgen Inc. | 12 | $155 |
| Hologic Sales and Service, LLC | 1 | $148 |
| AstraZeneca Pharmaceuticals LP | 6 | $125 |
| Abbott Laboratories | 5 | $108 |
| Inspire Medical Systems, Inc. | 1 | $101 |
| Exact Sciences Corporation | 3 | $87 |
Products named: Korlym, Ozempic, NURTEC ODT, MOUNJARO, APTIMA, FREESTYLE LIBRE 3, INSPIRE, ZEPBOUND.
Industry payments across MD — which companies pay providers there.
